Please assess the completion status of the following clinical trial:

Trial Title: MiMi: A Randomized Trial of Mifepristone and Misoprostol for Treatment of Early Pregnancy Failure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age \>18yrs, able to read and write English~* Intrauterine gestations with anembryonic sac between 10 and 45mm or~* 10-15mm sac with no growth in three days or other radiologic signs of abnormal pregnancy such as irregular sac or debris within the gestational sac~* An embryonic pole \<30mm with no cardiac activity~Exclusion Criteria:~* Intrauterine gestations with CRL \<5mm or \>30mm without cardiac activity~* Incomplete abortion as defined as open cervix and large amount of cramping/bleeding~* Hemodynamic instability and/or heavy vaginal bleeding~* Hemoglobin less than or equal to 8~* Inability to follow-up (ie, lack of transportation or access to telephone)~* Bleeding disorder or taking anticoagulants~* Prior medical or surgical treatment of the current pregnancy~* Obvious Infection~* Active Lactation~* Allergy to mifepristone or misoprostol~* Chronic corticosteroid use~* Severe gastrointestinal disease (e.g inflammatory bowel disease, severe gastritis)

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: t

Study Arms:
- Misoprostol and placebo (Type: ACTIVE_COMPARATOR): Women in this arm receive placebo and misoprostol 800 mcg buccally
- Mifepristone and misoprostol (Type: EXPERIMENTAL): Womwn in this group receive mifepristone 200 mg orally and misoprostol 800 mcg buccally

Based on this trial design, predict the completion outcome and termination type (if applicable).